大行評級|花旗:預計澳門博彩業首季EBITDA按年降6% 首選銀河娛樂及美高梅中國
花旗發表研究報告指,澳門今年首季的賭收平穩增長。雖然業界的再投資似乎仍維持在合理水平,但由於推出新酒店房間帶動成本上升,料期內的營運開支將會增加,由此導致的營運槓桿下降可能會使季內的行業EBITDA按年下降6%至19.16億美元。該行在澳門博彩股中首選銀河娛樂及美高梅中國,全球則首選拉斯維加斯金沙集團。
該行對金沙中國開啓爲期30天的下行催化劑觀察,預計集團今年首季的產業EBITDA將下跌至5.3億美元,按年及按季分別下跌13%及7%,市場佔有率則維持於23%的水平。不過,該行維持集團的“買入”評級,預期澳門倫敦人全面開業後,集團將成爲高級酒店市場的強大競爭對手。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.